Stay updated on Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes during the website transition appears above the 403 error page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T10:45:41.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.1 instead of v3.7.0. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T13:46:37.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the detailed study information and related documents with an error screen. This change blocks the ability to view core study details and attachments on the page.
    Difference
    18%
    Check dated 2026-09-23T21:45:58.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a new revision of the page content.
    Difference
    0.0%
    Check dated 2026-09-16T21:00:08.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a small update to the page documentation/metadata rather than substantive content.
    Difference
    0.0%
    Check dated 2026-09-02T19:55:48.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Added a funding attribution entry: '2015 ( U.S. NIH Grant/Contract )' under the study's external identifiers, indicating NIH support for this trial.
    Difference
    0.0%
    Check dated 2026-08-26T21:01:34.000Z thumbnail image

Stay in the know with updates to Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.